Status: Completed
ClinicalTrials.gov Identifier: NCT01796964
Alcon C-12-006: Injections of ESBA 1008 versus Eylea in subjects with wet AMD.
Condition: Exudative Age-Related Macular Degeneration
Study Type: Interventional
Duration: 17 months
Eligibility:
For additional information on this study, please click here
Back to Clinical Research